Understanding the Adoption of Buprenorphine for Opioid Addiction Treatment: A Qualitative Study

The opioid crisis has necessitated the adoption of effective treatment methods. Buprenorphine, a partial opioid agonist, has emerged as a critical tool in treating opioid addiction. This blog post delves into the comprehensive study by Green et al. (2022), which examines the factors influencing the adoption of buprenorphine in two not-for-profit integrated health plans.